04/172026

Heparins Manufacturer: Jiulong’s Full-Chain Traceability & Cross-Border Adaptation for Global Anticoagulant Supply

AstheglobalheparinAPImarketentersaperiodofsteadyrecoveryandrapidgrowth—withaprojectedvalueof31.08billionyuanin2026andaCAGRof13.07%through2033—pharmaceuticalpartners,distributors,andhealthcareprovide

Click to view

04/162026

Enoxaparin Sodium: Jiulong’s Patented Purification Technology for Global Anticoagulant Reliability

Astheglobaldemandforsafe,consistentanticoagulantscontinuestorise—withtheEnoxaparinSodiumAPImarketprojectedtogrowatasteadyCAGRandreachnewheightsby2031—pharmaceuticalpartnersworldwideareseekingatruste

Click to view

04/152026

Heparins Manufacturer: Jiulong’s Intelligent Quality Control for Global Anticoagulant Supply

Astheglobalanticoagulantmarketcontinuestoexpand—withtheglobalheparinAPImarketreachingUSD1.51billionin2025andprojectedtogrowata7.6%CAGRtoUSD2.51billionby2032—pharmaceuticalpartnersworldwideareseeking

Click to view

04/142026

Enoxaparin Sodium Manufacturer: Jiulong’s Eco-Friendly Production for Global Anticoagulant Demand

Astheglobalburdenofthromboembolicdisorderspersists—withtheEnoxaparinSodiumAPImarketreachingUSD227millionin2024andprojectedtohitUSD300millionby2031ataCAGRof4.2％—pharmaceuticalpartnersworldwideareseek

Click to view

04/132026

Dalteparin Sodium: Jiulong’s Cost-Efficient Precision Purification for Global Anticoagulant Markets

Astheglobalburdenofthromboembolicdisordersgrows—withtheDalteparinSodiummarketprojectedtoexpandatasteadyCAGRthrough2032—pharmaceuticalpartnersworldwideareseekingareliablesourceofthiscriticallowmolecu

Click to view

News and information